Sarissa Capital Reminds Amarin Shareholders Today Is the Last Day to Vote “FOR” ChangeBusiness Wire • 02/21/23
Amarin to Report Fourth Quarter and Full Year 2022 Financial Results And Host Conference Call on March 1st, 2023GlobeNewsWire • 02/21/23
Amarin Urges Shareholders to Vote “Against” Sarissa's Harmful Proposals at Upcoming General Meeting – IT HAS NO PLAN, NO NEW IDEAS AND AN UNDERQUALIFIED SLATEGlobeNewsWire • 02/17/23
Sarissa Capital Urges Amarin Shareholders to Vote for Change and Remake Amarin for ShareholdersBusiness Wire • 02/17/23
Sarissa Capital Blasts Amarin's Repeated False Statements; Clearly Amarin Will Say Anything to Keep Sarissa Off the BoardBusiness Wire • 02/16/23
Leading Independent Proxy Firm ISS Joins Glass Lewis in Recommending that Amarin Shareholders Vote “AGAINST” Sarissa's Value-Destructive ProposalsGlobeNewsWire • 02/16/23
Amarin Clearly and Definitively Instructed Registrar to Accept ALL Submitted Proxy CardsGlobeNewsWire • 02/16/23
Sarissa Capital Uncovers That Amarin's Registrar Had Not Been Instructed to Accept Blue Proxy Cards Even Though Legally Required to Do SoBusiness Wire • 02/15/23
Amarin Corporation plc (AMRN) SVB Securities Global Biopharma Conference (Transcript)Seeking Alpha • 02/15/23
Sarissa Capital Disappointed That Amarin Webcast Continues Board's Defense of Poor Results and Lack of AccountabilityBusiness Wire • 02/14/23
Amarin (AMRN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 02/14/23
Leading Independent Proxy Advisory Firm Glass Lewis Recommends that Amarin Shareholders Vote “AGAINST” All of Sarissa's ProposalsGlobeNewsWire • 02/14/23
Sarissa Capital Warns of Amarin's Expensive Attempts to Switch Votes by Inundating Shareholders With White Proxy CardsBusiness Wire • 02/13/23
Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa's Harmful ProposalsGlobeNewsWire • 02/09/23
Amarin Mails Letter to Shareholders Highlighting Sarissa's Myths vs. The FactsGlobeNewsWire • 02/06/23
Sarissa Capital Highlights Amarin's Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at AmarinBusiness Wire • 02/03/23
Amarin Mails Letter to Shareholders Highlighting New Board and Superior LeadershipGlobeNewsWire • 02/02/23
Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of ShareholdersBusiness Wire • 02/01/23
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New ZealandGlobeNewsWire • 01/27/23